Objective: To study autologous tissue engineered blood vessels (TEBV) in the descending aorta of juvenile sheep. Methods: Autologous vascular smooth muscle cells (vSMC) and endothelial cells were obtained from ovine carotid arteries. vSMC were seeded on bioresorbable scaffolds and dynamically cultured for 14 days. Following endothelialization an additional external ovine small intestinal submucosa wrapping was applied. Constructs were implanted in the descending aorta of juvenile sheep and removed after 1, 3, 6, 12 and 24 weeks for evaluation with histological, microscopical and biochemical techniques. Results: Up to 3 months after implantation, grafts were fully patent, without any signs of dilatation, occlusion or intimal thickening. Scanning electron microscopy revealed a confluent luminal endothelial cell layer. In contrast, the 6 months graft displayed significant dilatation and partial thrombus formation. Histology displayed layered tissue formation resembling native aorta. Extracellular matrix (ECM) stains, immunostaining and Transmission Electron Microscopy (TEM) revealed alternating layers of vSMC and extracellular matrix consisting of collagen, elastin and glycosaminogycans. Compared to native aorta, the elastin content of the TE grafts was significantly reduced. Conclusion: In this study, we report for the first time, the implantation of a TEBV in the descending aorta in a large animal model. TEBV were fully functional for up to 3 months. At 6 months the graft remained functional but significantly dilated, most likely caused by an insufficient elastic fiber synthesis. Hence, future studies need to focus on the stimulation of elastin synthesis in TEBV.
Introduction
Cardiovascular disease is the leading cause of death in industrialized countries. For treatment of coronary artery and peripheral vascular disease, large quantities of blood vessel substitutes are required. Currently, human autografts (vein or arteries) or prosthetic materials such as Dacronk are used for this purpose. However, these substitutes are either not able to grow and remodel or are prone to material related complications like stenosis, thrombosis, calcification and infection [1, 2] . For this reason the search for improved blood vessel substitutes remains unchallenged. Biological alternatives to the currently used prosthetic materials are tissue engineered (TE) autologous, living blood vessels substitutes. These substitutes have the potential to grow and remodel without any immunological complications. During the last years several promising attempts to tissue engineer blood vessels substitutes have been reported. In general they combine techniques from biological, engineering and medical sciences. In vitro and in vivo studies have proven the general feasibility of this approach [3] [4] [5] [6] [7] . However, several biological limitations need to be overcome before tissue engineered blood vessels substitutes (TEBV) become an alternative to the currently used prostheses.
The ultimate goal of tissue engineering is to produce blood vessel substitutes identical to their native counterpart. Native blood vessels consist of several layers of vascular smooth muscle cells embedded into an extracellular matrix and a luminal endothelial cell layer. The endothelial cell layer prevents thrombus formation and the media is responsible for contraction and mechanical stability of the blood vessel. Probably the most crucial issue in previous studies was the long-term patency of the constructs. TE blood vessel substitutes often displayed pathologically increased extracellular matrix (ECM) deposition and intimal thickening [7, 8] . A phenomenon probably caused by excessive proliferation and secretional activity of vascular cells. Recently we described the in vitro construction of ovine aortic blood vessels substitutes using autologous, enzymatically derived vascular smooth muscle and endothelial cells [9] . In the present study these blood vessels substitutes were evaluated after up to 6 month in vivo using histology, biochemical and ultrastructural methods to determine their functionality and the extent to which they resembled native aorta.
Materials and methods

In vitro culture of blood vessel substitutes
Tissue engineered aortic blood vessels substitutes were created as described previously [9] . In brief, sections of carotid arteries were harvested from 6-to 8-week-old lambs. vSMC and EC were isolated by enzymatic dispersion. vSMC were characterized by expression of alphasmooth-muscle-actin (Sigma, München, Germany), basiccalponin (DAKO Cytomation, Hamburg, Germany), heavy weight caldesmon (Sigma), smooth muscle myosin (Sigma) and the absence of von Willebrand factor (DAKO). EC were characterized by positive immunostaining for vWf and negative staining for alpha smooth muscle actin (ASMA). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA, USA) containing 10% fetal calf serum (Biochrom, Berlin, Germany) on tissue culture treated plastic ware (BD Biosciences, San Jose, CA, USA). Cells were passaged every 4 days. Approximately 23 ( F 2 days) days were required to obtain 15 confluent T75 tissue culture flasks. Subsequently, vSMC were sequentially seeded onto a custom made poly-4-hydroxybutyrate (P-4-HB) (Tepha, Cambridge, MA, USA) scaffold using a roller mixer [9, 10] . Seeded grafts were subjected to increasing laminar flow in a pulsatile bioreactor. Two days prior to implantation TE blood vessels substitutes were endothelialized with EC.
Preparation of small intestinal submucosa
In order to stimulate angiogenesis and increase mechanical stability, TEBV were wrapped into ovine small intestinal submucosa (SIS) prior to implantation. Segments of ovine small intestine (approximately 20 cm in length) were obtained from a local farm. Small intestines were cleaned by throughly washing with PBS (Invitrogen). This was followed by incubation in povidone-iodine-solution (Mundipharma, Limburg, Germany) solution for 15 min. Decontaminated segments were repeatedly washed with PBS and the mucosa and any connective tissue was removed mechanically [11] . The remaining SIS was transferred into PBS containing an antibiotic solution (1.2 mg amikacin, 3 mg flucytosin, 1.2 mg vancomycin, 0.3 mg ciprofloxacin, 1.2 mg metronidazol in 1 ml aqua ad inject.) and stored at 4 jC. Immediately prior to implantation, seeded TEBV were wrapped with the decellularized SIS.
Graft implantation
All animals received humane care in compliance with the ''Guide for the Care and Use of Laboratory Animals'' published by the National Institutes of Health (NIH publication no. 85-23, revised 1985) . Autologous grafts were implanted into the descending aorta of juvenile sheep replacing an approximately 4 cm long segment. No postoperative anticoagulation was administered. After 1, 3, 6, 12 and 24 weeks in the animals the TEBV were explanted. An adjacent segment of native aorta was explanted for comparision. Explanted tissues were processed immediately or frozen in liquid nitrogen and stored at À 80 jC until analysis.
Histology
Tissue samples were fixed in 4% paraformaldehyde in cacodylatebuffer for at least 72 h. Subsequently, samples were embedded in parafin and 5 Am sections were cut and stained using H&E, Hart's, Movat Pentachrom, van Kossa and Resorcin-Fuchsin staining as described previously [12] .
Protein extraction
Tissue samples were frozen using liquid nitrogen and homogenized in a mortar. Protein extraction buffer was added to the sample with subsequent incubation on a vortex shaker for 2 h at 4 jC. Tissue debris were pelleted by centrifugation. The supernatant was collected and protein content was determined using a commercially available protein kit (Biorad, Hercules, CA). Samples were shockfrozen and stored at À 80 jC for subsequent analysis.
Desmosine quantification
Desmosine content of samples was determined using a radioimmunoassay for desmosine as described previously [13] . From each vessel three samples were analyzed.
Immunohistology
Paraffin imbedded tissue samples were cleared by washing with Xylene followed by gradual washing with ethanol (100%, 80%, 50%). Paraffin free sections were incubated in blocking buffer (PBS containing 0.1% Triton-X-100 and 2% skim milk) for 1 h. Slides were washed with PBS-T (PBS containing 0.1% Triton-X-100). Collagen type I, III and IV antibodies (all DAKO), Elastin, smooth muscle myosin, alpha smooth muscle actin and desmin (all Sigma) were diluted according to instructions in PBS and 150 Al antibody solution was applied to the sections. Slides were incubated in a moist chamber for 2 h at 37 jC and then washed repeatedly with PBS-T. FITC conjugated secondary antibodies (diluted in PBS containing DAPI) were applied followed by incubation at 37 jC for 1 h. Samples were washed repeatedly with PBS-T and analyzed immediately using a fluorescence microscope (Axiovert S 100, Zeiss, Jena, Germany).
Electron microscopy
Specimens for transmission electron microscopy (TEM) were fixed at room temperature in 2% glutaraldehyde (Sigma) in cacodylate-buffer for 30 min. Specimens were further fixed in osmium tetroxide (Sigma), dehydrated in graded alcohol and embedded in araldite. Ultrathin sections were stained with lead acetate and lead citrate (Serva). Samples were investigated on a transmission electron microscope (EM 900, Zeiss, Oberkochen, Germany).
Specimens for scanning electron microscopy (SEM) were fixed in 4% paraformaldehyde for 24 h. Fixed specimens were dehydrated in an alcohol gradient (40%, 60%, 80% and 99.9%, 10 min each). Samples were critical point dried using a critical point drier CPD030 (BAL-TEC, Balzers, Liechtenstein) and mounted on stubs for SEM. Mounted samples were subsequently coated with gold using a sputter coating device SCD005 (BAL-TEC). Samples were analyzed using a scanning electron microscope LEO-1450 VP (LEO, Oberkochen, Germany).
Near infrared femtosecond multiphoton laser scanning microscopy
Near infrared femtosecond multiphoton laser scanning microscopy (LSM) was performed as previously described [14] . Immediately after dissection, native and TE specimens were investigated at wavelengths of 760 and 840 nm to induce ECM component dependent autofluorescence as well as second harmonic generation (SHG) [15] . Owing to the high near infrared penetration depth, non-invasive serial optical horizontal sections of the different vessel specimens were taken in z-steps of 5 and 10 Am within a depth of 0 -100 Am.
Statistical analysis
An unpaired t-test was used to determine significant deviations. p-Values smaller than 0.05 were considered to be significant. 
Results
Macroscopical appearance
After one week in vivo the graft displayed a shiny surface with some irregular regions due to protruding polymer (Fig. 1 ). Up to 6 weeks after implantation grafts were completely patent and displayed no signs of dilatation. The internal surface was smooth and shiny without any evidence of thrombus formation. Anastomoses were smooth and not stenosed. On the external side of the blood vessel distinct in-growth of small blood vessels into the SIS-layer was visible. After 12 weeks in vivo, vessels were still completely patent and displayed no signs of intimal thickening, dilatation or stenoses. However, two small areas of thrombus formation were observed. In contrast, the graft cultured for 24 weeks was still patent but clearly dilatated.
In addition increased thrombus formation was observed in the dilated graft.
Histology
Luminal surface
SEM and immunohistology confirmed a confluent endothelial cell lining. SEM revealed a confluent layer of cells with cobblestone morpholgy (Fig. 2A) . A monolayer of vWf positive and ASMA negative cells was detected in histolgy sections (Fig. 2B) . In addition the luminal cell layer stained positive for the endothelial cell marker CD31 (data not shown). Cells in the TEBV were more rounded than native endothelial cells. As observed in the native aorta ECs aligned parallel to the direction direction of blood flow. TEM of luminal cells revealed features typical for endothelial cells (Fig. 2C) . Cells displayed peripheral chromatin condensation in the nucleus and many membrane bound cytoplasmatic vesicles. In line with the macrosopic findings the dilated graft displayed massive deposition of fibrilar structures and thrombus on top of the endothelial cell layer.
Histology
H&E staining revealed a major increase in cell layers during the first 3 weeks and a slower increase during the following weeks (Fig. 3) . Tissue was arranged in layers with alternating layers of ECM and perpendicular aligned vSMC resembling the gross appearance of native ovine aorta. Replacement of polymeric material with tissue was observed during in vivo culture. No signs of inflammation such as leukocyte infiltration or ''giant cells'' were observed in histology sections.
Resorcin-Fuchsin as well as Hart's staining revealed a significant lack in elastin structures in TEBV (Fig. 4A,B) . Compared to native aorta only a fraction of elastic fibers was detected in TE-vessels. The deminished amount of elastic fibers in the TEBV was observed throughout the entire in vivo culture period. Most of the elastic structures were found in the luminal part of the media. In contrast, native aorta displayed distinct elastic lamellae throughout the arterial wall. These findings were confirmed by immunostaining with Elastin specific antibodies (Fig. 5D ). Native aortas stained strongly positive for elastin. Elastin was confined to the predominantly accelular ECM layers. In contrast, elastin staining was much less distinct in TEBV and its distribution was more diffuse. Staining of cellular regions in the TEBV suggested ongoing (tropo-)elastin synthesis.
Movat pentachrome staining revealed that collagen and ground substance (GAG, Fibronectin) were the predominant matrix components of TEBV (Fig. 4C) . Native aorta also displayed the presence of collagen and GAG but elastic fibers appeared to be present in the highest concentration. Immunostaining revealed that collagen consisted of Collagen type I and Collagen type III fibrils as well as more difusely distributed Collagen IV in the TE-vessels and in native aorta (Fig. 5A -C) . In contrast, immunostaining for fibronectin was much stronger in the TEBV than in native aorta (Fig. 5F ).
Desmosine quantification
Desmosine, which is a an amino acid cross-link specific to elastin, was quantitated as a measure of elastin content. The desmosine content in TEBV was significantly reduced compared to native aorta (Fig. 6 ). Although the desmosines increased significantly from week 1 (81.0 pmol/mg protein) to week 3 (193.7 pmol/mg protein) after three weeks no further increase could be detected and values remained significantly lower than in native aorta (4271.0 pmol/mg protein).
Ultrastructure
TEM of TEBV revealed a layered arrangement of cells and extracellular matrix (Fig. 7A) . Striated collagen fibrils were the major components of the ECM in TE blood Fig. 3 . H&E stains of native aorta and TEBV 1,3,6, 12 and 24 weeks after implantation. Note polymeric scaffold residues in the outer layers of the constructs. Most of the P-4-HB was dissolved during the embedding process resulting in empty spaces in these regions. vessels. Elastin was observed as well but to a much lesser extent than collagen fibrils. In contrast the major ECMcomponent of native aorta was elastin. Striated collagen fibrils were also observed in the native aorta however less abundant than in TEBV (Fig. 7B ). Elastic and collagen fibers were co-localized in the lamella of native blood vessels. Cells growing in the polymeric region displayed many cytoplasmatic vesicles indicating ingestion of P-4-HB (Fig. 7C ).
Near infrared femtosecond multiphoton laser scanning microscopy
Near infrared femtosecond multiphoton laser scanning microscopy was performed with the TEBV cultured for 24 weeks in vivo and native ovine aorta. With near infrared multiphoton excitation at 760 nm, a distinct elastic fiber system was visualized throughout the native specimens (Fig. 8A -C) . In contrast, only a few elastin con- taining structures were visible at the inner surface of the TEBV (Fig. 8D -F) . Excitation at 860 nm revealed that organized collagenous fibers were dominant in the TEBV.
In contrast, collagenous fibers were less prevalent in native tissues. These findings correlate well with the (immuno)-histologic observations. 
Expression of vSMC differentiation markers
Both native aorta and TEBV expressed alpha smooth muscle actin and smooth muscle myosin in the medial cell layers. While expression of desmin was not observed in the medial cell layers (Fig. 9) . In contrast the luminal endothelial cells did not stain positive for these vSMC marker proteins (arrows).
Discussion
In this study, autologous, living tissue engineered blood vessels (TEBV) were implanted in the descending aorta of juvenile sheep and allowed to remain for up to 6 months in vivo. The general feasibility of this approach and several important issues concerning the in vivo behavior of tissue engineered blood vessel substitutes were addressed.
Most previous studies focussed either on implanting TE blood vessels in the low-pressure circulation or using very durable scaffold materials [3, 7] . However, very durable scaffolds are problematic since the scaffolds interfere with tissue formation and can cause inflammatory responses [16] . In contrast to scaffolds like polyhydroxyoktanoates, P-4-HB based scaffolds degrade in vivo within months [17] . Patch augmentation of the pulmonary artery with seeded P-4-HB has been performed successfully [18] .
In the present study, P-4-HB was used as scaffolding material to tissue engineer an entire segment of the descending aorta in a large animal model. In spite of a rather short in vitro time span prior to implantation (14 days), all blood vessels withstood systemic blood pressure for up to 3 months. This positive result is most likely related to the high elasticity of the P-4-HB scaffolds and the presence of already organized tissue at the time of implantation. Application of decellularized small intestine submucosa resulted in additional stability of the construct and facilitated angiogenesis. As expected, the scaffolding material was rapidly replaced by tissue and after 6 months in vivo the scaffold material was almost completely absorbed. Minimizing the in vitro time span prior to implantation resulted in the implantation of a rather immature graft. Thus, rapid in vivo maturation was required, and in fact was observed during the first weeks following implantation. Histology revealed that after 3 weeks in vivo, a newly formed tissue with a mulitlayered ECM alternating with vSMC layers was present. Our results suggested that tissue formation reached a peak in the first 6 weeks in vivo and slowed down subsequently. All vessels remained patent throughout the entire study (24 weeks) displaying no signs of occlusion or increased wall thickness. Medial vSMC displayed markers of late vSMC differentiation indicating a mature differentiated phenotyp, characteristic for physiological blood vessels. These findings are particularly important since most previous studies observed massive intimal thickening and pathologically increased matrix synthesis resulting in early graft occlusion which was probably caused by dedifferentiation and unlimited proliferation of medial vSMC [7, 8] . The use of homogenous vSMC populations in this study obviously avoids the problem of intimal thickening.
In contrast to studies with tissue engineered structures based on xenogenous and acellular matrix, no calcification was observed. Recent studies linked calcification to the presence of xenogenous material (cellular debris, xenogenous ECM). The use of a polymeric scaffold obviously avoids this problem. Unlike other studies in which polymeric materials such as PGA were employed no inflammatory response was observed in the P-4-HB based scaffolds.
Inspite of these positive results, a limitation concerning the ECM structures became apparent in the dilated graft at 24 weeks. The ECM of TEBV were arranged in layers similar to native aorta. However, in contrast to native aorta, elastic fibers were almost absent in the ECM layers and layer formation was less distinct.
Elastic fibers are crucial components of blood vessels and particularly in elastic arteries, providing elasticity and flexibility. Compared to native tissue significantly less elastic fibers were formed in tissue engineered constructs and the fibers that were present were poorly organized. The TE constructs showed a marked decrease in desmosine content compared to native aorta. This could reflect less elastin or a reduced level of the actual cross-links. When considered together with the histological data, the lower desmosine content probably indicates less elsatin deposited in the matrix.
Instead of elastic fibers collagen and GAGs and fibronectin were the major components of the ECM. GAG was dominating during early in vivo culture and was successively replaced by collagen. As described before for native arteries [19] , the dominant collagens were types I and III. In addition collagen type IV, a component of the basal lamina, surrounded the vSMC. Collagenous fibers still provided sufficient stability to avoid graft rupture but they were not able to provide the required elastic properties. The fact that elastic fiber formation was reduced significantly in all TEBV strongly suggests that the observed dilatation was not an incidential event. During the first few weeks following implantation the lack of mature elastic components was well compensated for by the elasticity of the polymeric scaffold. However, after degradation of the scaffold material the newly formed tissue was too weak to withstand the aortic blood pressure resulting in a dilatation. The observed lack in mature elastin structures in TEconstructs was described previously [5, 6] and seems to be a serious limitation for tissue engineering functional TEBV for the high pressure circulation. Synthesis of the highly cross-linked elastin network seems to be one of the most complex process during maturation of blood vessels. During normal embryogenesis several, complex physical and biochemical signals are involved in blood vessel maturation [20] . Medial vascular smooth muscle cells undergo a sequential differentiation program during embryogenisis [21] . In this study a bioreactor system was used to mimic the increasing flow conditions. While we observed that pulsatile flow increased elastin deposition during in vitro culture, the total amount of elastin was still dramatically reduced [9] . Obviously, additional biomechanical or biochemical signals are required for a physiological elastin synthesis.
Hence future studies will need to focus on strategies to improve mature, cross-linked elastic fiber formation in TEBV. It has been reported previously that application of TGF-ß1 and insulin increases elastin snthesis in vitro [22] . Other substances known to increase elastogenesis are calcitriol [23] and retinoic acid [24, 25] . The thermoplastic nature of the P-4-HB scaffolds used in this study allows incorporation of these molecules. Another option is to transfect vSMC with the lysyl oxidase gene, known to be required for cross-linking ECM proteins like collagen or elastin (26) . The availibilty of the near infrared laser scanning microscopy technique to monitor elastic fiber formation can facilitate further studies.
Thrombus formation is another recognized problem in vascular grafts which is probably related to the presence of an intact, functional endothelium. In this study TEBV possessed a confluent endothelial layer consisting of vWf positive cells. In spite of complete endothelialization, localized thrombus formation was observed after 12 and 24 weeks. While in the latter case this is most likely a consequence of disturbed flow conditions due to the dilatation, the reason in the 12 weeks graft remains unclear. A possible clinical solution to this problem may be low dose anticoagulation therapy after implantation. However, further studies with larger sample sizes are necessary to study thrombogenicity and endothelial functionality.
Due to the systemic pressure in the descending aorta, and the weak mechanical stability of unseeded P-4-HB, it was not possible to implant any control groups. In a previous study it was demonstrated that unseeded PHB patches implanted in the pulmonary artery did not support organized tissue formation sufficiently [18] . This result was confirmed by studies with other polymeric scaffolds implanted without cell seeding [27] . Migration of cells from the adjacent native aorta in-and onto the TEBV cannot be excluded completely. However, the equal distribution of tissue over the entire length of the construct after a short period in vivo strongly support the assumption that the tissue was indeed derived from the seeded cells. This assumption is further supported by the fact that vSMC in the TE-grafts resemble carotid vSMC, which display a more elongated morphology than aortic vSMC.
In conclusion, this early in vivo study reports for the first time the implantation of a TEBV in the descending aorta in a large animal model. The TEBV resembled native aorta and remained patent throughout the study. However, after 6 months significant dilatation of the graft was observed. This was most likely caused by the inability of the cells in the TEBV to synthesize or assemble the normal complement of elastic fibers in the new matrix of the engineered vessels. Future studies with larger sample groups will have to focus on possibilities to support elastic fiber formation and the issue of thrombogenicity. Ultimately we envision transfering the technique to small diameter vessels which are clinically more relevant then aorta descendens. 
